ImageneBio Inc
42 hedge funds and large institutions have $293M invested in ImageneBio Inc in 2021 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 7 closing their positions.
214% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 7
167% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 3
56% more funds holding
Funds holding: 27 → 42 (+15)
5.36% less ownership
Funds ownership: 64.12% → 58.76% (-5.4%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
46% less capital invested
Capital invested by funds: $539M → $293M (-$245M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$12M |
| 2 |
BlackRock
New York
|
+$6.67M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$5.11M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.94M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
+$3.08M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$4.27M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$3.21M |
| 3 |
LGM
Logos Global Management
San Francisco,
California
|
-$2.21M |
| 4 |
Goldman Sachs
New York
|
-$1.1M |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$812K |
IMA Hedge Fund Activity: Q2 2021 in Review
42 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q2 2021, worth a combined $293M — down 46% from $539M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new IMA positions and 7 closed out — a net gain of 15 holders — while 8 added to existing stakes and 3 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $12M. The largest seller was Farallon Capital Management, cutting an estimated $4.27M.
- 42 institutional investors held ImageneBio Inc (IMA) as of Q2 2021, up from 27 in Q1 2021.
- Funds reported $293M of ImageneBio Inc stock for Q2 2021, down 46% quarter-over-quarter.
- 22 funds opened new ImageneBio Inc positions in Q2 2021 and 7 closed out, a net change of +15 holders.
- The largest ImageneBio Inc buyer in Q2 2021 was Fidelity Investments, an estimated $12M added.
- The largest ImageneBio Inc seller in Q2 2021 was Farallon Capital Management, an estimated $4.27M sold.
Based on aggregated 13F filings for Q2 2021.